ESC 365 - Comparative safety and efficacy of combination lipid lowering therapy versus high-intensity statin in elderly patients with atherosclerotic cardiovascular disease

ESC2025 Premium Access

Comparative safety and efficacy of combination lipid lowering therapy versus high-intensity statin in elderly patients with atherosclerotic cardiovascular disease

Session: Cardiovascular disease in older adults (1)

Topic: Cardiovascular Disease in the Elderly

Speaker: Doctor J. Cha (Seoul, KR)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Jung-Joon Cha

Korea University Anam Hospital, Seoul (Korea (Republic of))

0 follower

7 more presentations in this session

Association of GlycA, a composite 1H-NMR marker of systemic inflammation, with LDL particle size, frailty and epigenetic age acceleration

Speaker: Associate Professor E. Fung (Hong Kong, CN)

Clinical outcomes of drug-coated balloon vs. drug-eluting stent in octogenarians with coronary artery disease: a propensity score-matched study

Speaker: Professor A. Her (Chuncheon, KR)

Baseline levels of amino acid metabolites are associated with clinical outcomes in older persons

Speaker: Doctor C. Wang (Beijing, CN)

Diagnostic value of 24-hour holter monitoring in nonagenarians: a single-center cohort study

Speaker: Doctor A. Fonseca Vazao (Leiria, PT)

Combined effect of frailty and sarcopenia on the risk of cardiovascular disease: a longitude analysis in middle-aged and older adults

Speaker: Miss M. Liu (Beijing, CN)

Access the full session

Cardiovascular disease in older adults (1)

Speakers: Doctor J. Cha, Associate Professor E. Fung, Professor A. Her, Doctor C. Wang, Doctor A. Fonseca Vazao...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources